Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

Purpose. To report the efficacy of subconjunctival triamcinolone (Kenalog A-40, Alcon) and bevacizumab (Avastin, Genentech) injections in fraternal twins with blepharokeratoconjunctivitis (BKC) causing progressive, bilateral corneal neovascularization and scarring. Methods. In this retrospective obs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chu Luan Nguyen, Tony S. Chen, Khoi Tran, James E. H. Smith, Noni Lewis
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Case Reports in Ophthalmological Medicine
Online Access:	http://dx.doi.org/10.1155/2018/2602487
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

To evaluate the efficacy of subconjunctival bevacizumab injection in vascular pterygium before surgical excision in preventing recurrence comparing with bare sclera technique
by: Nusrat Shaheen, et al.
Published: (2025-01-01)

Efficacy Of Triamcinolone Injection In Management Of Oral Lichen Planus
by: Humera Iqbal, et al.
Published: (2024-03-01)

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis
by: Junko Yoshida, et al.
Published: (2015-01-01)

Serum Triamcinolone Levels following Cervical Interlaminar Epidural Injection
by: Tim J. Lamer, et al.
Published: (2018-01-01)

Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
by: Sertan Goktas, et al.
Published: (2014-01-01)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
by: Belghmaidi Sarah, et al.
Published: (2016-01-01)

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)

Bilateral Severe Sterile Inflammation with Hypopyon after Simultaneous Intravitreal Triamcinolone Acetonide and Aflibercept Injection in a Patient with Bilateral Marked Rubeosis Associated with Ocular Ischemic Syndrome
by: Ceren Durmaz Engin, et al.
Published: (2017-01-01)

Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
by: Bing Liu, et al.
Published: (2022-01-01)

Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
by: Toshiyuki Oshitari, et al.
Published: (2015-01-01)

Unilateral Subconjunctival and Retrobulbar Hemorrhage Secondary to Brodifacoum Toxicity in a Dog
by: Sonia E. Kuhn, et al.
Published: (2013-01-01)

Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
by: Yanxia Zhu, et al.
Published: (2022-01-01)

Association Of Conjunctival Vitreous Reflux With Intraocular Pressure Spikes After Intravitreal Bevacizumab Injection
by: Kanwal Zareen Abbasi, et al.
Published: (2024-04-01)

Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome
by: Joseph Pikkel, et al.
Published: (2013-01-01)

Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
by: Emergency Medicine International
Published: (2024-01-01)

Photopsias during Systemic Bevacizumab Therapy
by: Heather Leisy, et al.
Published: (2016-01-01)

Eye to eye with Loa loa: A rare subconjunctival encounter in a nonendemic region
by: Simran, et al.
Published: (2025-01-01)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
by: Leila El Matri, et al.
Published: (2012-01-01)

Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population
by: Amber khalid, et al.
Published: (2025-01-01)

Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
by: Hossein Ashraf, et al.
Published: (2025-06-01)

Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage
by: Jiao Lv, et al.
Published: (2018-01-01)

Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane)
by: Naoki Matsuoka, et al.
Published: (2015-01-01)

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
by: Tatsuya Yunoki, et al.
Published: (2013-01-01)

Bevacizumab-Induced Reversible Thrombocytopenia in a Patient with Adenocarcinoma of Colon: Rare Adverse Effect of Bevacizumab
by: Jeevan Kumar, et al.
Published: (2012-01-01)

Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
by: Agnieszka Nowosielska, et al.
Published: (2024-03-01)

Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
by: Sofia Mickaela Martinez, et al.
Published: (2025-01-01)

The Effect of Bevacizumab and Propranolol on Nasal Polyposis
by: Yuksel Olgun, et al.
Published: (2022-01-01)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
by: Cheng-Jiang Liu, et al.
Published: (2021-01-01)

Bevacizumab: A Rare Cause of Nonischemic Cardiomyopathy
by: Oreoluwa Oladiran, et al.
Published: (2018-01-01)

In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
by: Yuanyuan Zhang, et al.
Published: (2019-01-01)

A curative effect evaluation of intensity-modulated radiation therapy combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease patients with active extraocular muscle but low CAS
by: Hao Zhang, et al.
Published: (2025-01-01)

Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review
by: Sapna Sadarangani, et al.
Published: (2014-01-01)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
by: Deli Krizova, et al.
Published: (2014-01-01)

Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab
by: Dávid Csercsik, et al.
Published: (2019-01-01)

Manufacture and Characterization of Mucoadhesive Buccal Films Based on Pectin and Gellan Gum Containing Triamcinolone Acetonide
by: Felipe Pereira Fernandes, et al.
Published: (2018-01-01)

The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
by: Chunmei Gan, et al.
Published: (2025-03-01)

Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study
by: Ayman G. Elnahry, et al.
Published: (2020-01-01)

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
by: J. Fernando Arevalo, et al.
Published: (2011-01-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)